CVC  Alexandria Venture Investments

http://www.are.com/





     Office Locations:

400 Technology Square, Suite 101
Cambridge, MA 02139
Phone: 617-661-6962

Get all office locations for this firm with a National Database subscription or New York Database subscription.
 

Stages:

  • Early
  • Seed


 

Industries:

  • Energy & Clean Tech
  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Alexandria Venture Investments is the strategic investment entity of Alexandria Real Estate Equities, Inc. (ARE: NYSE). Alexandria Equities provides capital to the broad and diverse life science sector. Since 1994, Alexandria Real Estate has created first-in-class life science clusters that foster innovative and collaborative environments in key locations immediately proximate to leading research institutions. Alexandria's diverse tenant base includes internationally renowned academic and medical institutions, multinational pharmaceutical companies, leading private and public biotechnology entities, non-profit institutions, government agencies, medical device companies, biofuels companies, research tools and service companies, and venture capitalists.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Andres Gavinet Chief Accounting Officer
    Daniel J. Ryan Co-Chief Investment Officer & Regional Market Director
    Dean A. Shigenaga Chief Financial Officer & President
    Joel S. Marcus Executive Chairman & Founder
    John Cunningham Executive Vice President, Regional Market Director

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      02/08/2024


      Neurona Therapeutics


      CA


      $120,000,000


      Venture


      12/04/2023


      Seismic Therapeutic


      MA


      $121,000,000


      Series B


      10/13/2023


      ROME Therapeutics


      MA


      $149,000,000


      Series B


      09/28/2023


      Deka Biosciences


      MD


      $20,000,000


      Series B-2


      06/22/2023


      AltPep


      WA


      $52,900,000


      Series B


      05/03/2023


      Ten63 Therapeutics


      NC


      $15,900,000


      Series A


     

    Portfolio companies include:


      Adaptive Phage Therapeutics
        web link


      Affinia Therapeutics
        web link


      Alloy Therapeutics
        web link


      AltPep
        web link


      Ambys Medicines
        web link


      Arrakis Therapeutics
        web link


      Aura Biosciences
        web link


      Avelas Biosciences
        web link


      Avidity Biosciences
        web link


      AXONIS Therapeutics
        web link


      Benson Hill Biosystems
        web link


      Blacksmith Medicines
        web link


      BlackThorn Therapeutics
        web link


      Boragen


      Boundless Bio
        web link


      Capstan Therapeutics
        web link


      Cardea Bio
        web link


      Chroma Medicine
        web link


      Cibus
        web link


      Compass Therapeutics
        web link


      Crop Enhancement


      Cydan
        web link


      Deka Biosciences
        web link


      DiCE Molecules
        web link


      Disc Medicine
        web link


      Dren Bio
        web link


      Ensoma
        web link


      EpiBiome
        web link


      Garuda Therapeutics
        web link


      GeneCentric Therapeutics
        web link


      GNS Healthcare
        web link


      Greenlight Biosciences


      Gritstone Oncology
        web link


      Homology Medicines
        web link


      IgGenix
        web link


      Imara
        web link


      ImmuneID
        web link


      Immunitas Therapeutics
        web link


      Immusoft


      Inari
        web link


      Insitro
        web link


      Jasper Therapeutics
        web link


      Kallyope
        web link


      Karuna Pharmaceuticals
        web link


      Korro Bio
        web link


      Maze Therapeutics
        web link


      Metacrine
        web link


      miRecule
        web link


      Molecular Assemblies
        web link


      MouSensor
        web link


      Mozart Therapeutics
        web link


      Neurogene
        web link


      Neurona Therapeutics
        web link


      Nitrome Biosciences


      OncoResponse
        web link


      ORIG3N
        web link


      Ozette Technologies
        web link


      Parthenon Therapeutics
        web link


      Pheast Therapeutics
        web link


      Pleno
        web link


      Prevail Therapeutics
        web link


      Redpin Therapeutics
        web link


      Relay Therapeutics


      RGenix
        web link


      Ribometrix
        web link


      Ring Therapeutics
        web link


      ROME Therapeutics
        web link


      Seismic Therapeutic
        web link


      Senda Biosciences
        web link


      SeQure Dx
        web link


      Silverback Therapeutics
        web link


      Sonoma Biotherapeutics
        web link


      SonoThera
        web link


      Stoke Therapeutics
        web link


      Strand Therapeutics
        web link


      StrideBio
        web link


      TARA Biosystems
        web link


      Ten63 Therapeutics
        web link


      Tiamat Sciences
        web link


      Tiburio Therapeutics
        web link


      TORL BioTherapeutics


      TwinStrand Biosciences
        web link


      Ubiq Security
        web link


      Vera Therapeutics
        web link


      Verseau
        web link


      Visterra
        web link


      Vividion Therapeutics
        web link


      Vor Biopharma
        web link


      X-Vax Technology
        web link


      Xilis


     

    Recent News: